View in EDS HTML Full Text PDF Full Text

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the Novel Long-Acting FGF21 Analog Zalfermin.

Saved in:
Bibliographic Details
Title: Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the Novel Long-Acting FGF21 Analog Zalfermin.
Authors: Dahl K; Novo Nordisk A/S, Bagsværd, Denmark., Friedrichsen MH; Novo Nordisk A/S, Bagsværd, Denmark., Ribel-Madsen R; Novo Nordisk A/S, Bagsværd, Denmark., Hansen JS; Novo Nordisk A/S, Bagsværd, Denmark., Clausen JO; Novo Nordisk A/S, Bagsværd, Denmark., Axelsen M; Gubra A/S, Hørsholm, Denmark., Palle MS; Novo Nordisk A/S, Bagsværd, Denmark., Lippert SL; Novo Nordisk A/S, Bagsværd, Denmark., Björkdahl O; Novo Nordisk A/S, Bagsværd, Denmark., Toubro S; Novo Nordisk A/S, Bagsværd, Denmark., Key C; ICON Early Phase Service, San Antonio, Texas, USA., Andersen B; Novo Nordisk A/S, Bagsværd, Denmark.
Source: Clinical and translational science [Clin Transl Sci] 2025 Dec; Vol. 18 (12), pp. e70435.
Publication Type: Journal Article; Randomized Controlled Trial; Clinical Trial, Phase I
Journal Info: Publisher: WileyBlackwell Pub Country of Publication: United States NLM ID: 101474067 Publication Model: Print Cited Medium: Internet ISSN: 1752-8062 (Electronic) Linking ISSN: 17528054 NLM ISO Abbreviation: Clin Transl Sci Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41351276
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the Novel Long-Acting FGF21 Analog Zalfermin.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Dahl+K%22">Dahl K</searchLink>; Novo Nordisk A/S, Bagsværd, Denmark.<br /><searchLink fieldCode="AU" term="%22Friedrichsen+MH%22">Friedrichsen MH</searchLink>; Novo Nordisk A/S, Bagsværd, Denmark.<br /><searchLink fieldCode="AU" term="%22Ribel-Madsen+R%22">Ribel-Madsen R</searchLink>; Novo Nordisk A/S, Bagsværd, Denmark.<br /><searchLink fieldCode="AU" term="%22Hansen+JS%22">Hansen JS</searchLink>; Novo Nordisk A/S, Bagsværd, Denmark.<br /><searchLink fieldCode="AU" term="%22Clausen+JO%22">Clausen JO</searchLink>; Novo Nordisk A/S, Bagsværd, Denmark.<br /><searchLink fieldCode="AU" term="%22Axelsen+M%22">Axelsen M</searchLink>; Gubra A/S, Hørsholm, Denmark.<br /><searchLink fieldCode="AU" term="%22Palle+MS%22">Palle MS</searchLink>; Novo Nordisk A/S, Bagsværd, Denmark.<br /><searchLink fieldCode="AU" term="%22Lippert+SL%22">Lippert SL</searchLink>; Novo Nordisk A/S, Bagsværd, Denmark.<br /><searchLink fieldCode="AU" term="%22Björkdahl+O%22">Björkdahl O</searchLink>; Novo Nordisk A/S, Bagsværd, Denmark.<br /><searchLink fieldCode="AU" term="%22Toubro+S%22">Toubro S</searchLink>; Novo Nordisk A/S, Bagsværd, Denmark.<br /><searchLink fieldCode="AU" term="%22Key+C%22">Key C</searchLink>; ICON Early Phase Service, San Antonio, Texas, USA.<br /><searchLink fieldCode="AU" term="%22Andersen+B%22">Andersen B</searchLink>; Novo Nordisk A/S, Bagsværd, Denmark.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101474067%22">Clinical and translational science</searchLink> [Clin Transl Sci] 2025 Dec; Vol. 18 (12), pp. e70435.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Randomized Controlled Trial; Clinical Trial, Phase I
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22WileyBlackwell+Pub%22">WileyBlackwell Pub </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101474067 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1752-8062 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2217528054%22">17528054 </searchLink><i>NLM ISO Abbreviation: </i>Clin Transl Sci <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41351276
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1111/cts.70435
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: e70435
    Titles:
      – TitleFull: Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the Novel Long-Acting FGF21 Analog Zalfermin.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Dahl K
      – PersonEntity:
          Name:
            NameFull: Friedrichsen MH
      – PersonEntity:
          Name:
            NameFull: Ribel-Madsen R
      – PersonEntity:
          Name:
            NameFull: Hansen JS
      – PersonEntity:
          Name:
            NameFull: Clausen JO
      – PersonEntity:
          Name:
            NameFull: Axelsen M
      – PersonEntity:
          Name:
            NameFull: Palle MS
      – PersonEntity:
          Name:
            NameFull: Lippert SL
      – PersonEntity:
          Name:
            NameFull: Björkdahl O
      – PersonEntity:
          Name:
            NameFull: Toubro S
      – PersonEntity:
          Name:
            NameFull: Key C
      – PersonEntity:
          Name:
            NameFull: Andersen B
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 12
              Text: 2025 Dec
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 1752-8062
          Numbering:
            – Type: volume
              Value: 18
            – Type: issue
              Value: 12
          Titles:
            – TitleFull: Clinical and translational science
              Type: main
ResultId 1